title: [Treatment of life-threatening airway obstruction in patients with malignant lymphomas].
abstract: Case histories of patients with hemoblastosis admitted to a hospital for acute respiratory failure due to tumor-induced obstruction were retrospectively analyzed. The causes of obstruction, antitumor therapy, methods for provision of airway patency, and major critical syndromes were analyzed. Ten patients with life-threatening tumor-induced airway obstruction were hospitalized from 1995 to 2007. The patients suffered from malignant lymphomas in all cases. The causes of impaired airway patency were the compression of the trachea and large bronchi with a tumor, lymph nodes, affected thyroid, as well as the superior vena cava syndrome, and tumor-induced lesion of soft tissues of the neck and chest. Airway patency was effected with tracheal intubation in 9 cases, it was maintained by noninvasive mask ventilation in 1 patient. Translaryngeal tracheal intubation and tracheostomy were used for artificial ventilation (AV) in 6 and 3 patients, respectively. Multidrug therapy (MDT) was performed in all the patients. Airway patency restored in 9 patients after MDT initiation. The duration of AV was 5.8 +/- l.7 days. The length of stay in an intensive care unit was 90%; intrahospital survival was 70%; 28-day and 3-year survivals were 90 and 24%, respectively. Two of the 3 patients who had undergone were observed to have serious complications (cicatrical stenosis, tracheoesophageal fistula). Hemoblastosis patients with tumor-induced obstruction need for provision of airway patency and for immediate initiation of MDT and/or radiotherapy. Orothracheal or nasotracheal intubation of the trachea is the methods of choice in providing airway patency. Tracheostomy is not indicated in most cases. Short-term prognosis is good in this cohort of patients. Long-term prognosis is determined by a lot of factors of which tumor sensitivity to cytostatics and radiation is most important.
authors.forename: G M
authors.initials: GM
authors.lastname: Galstian
authors.forename: S A
authors.initials: SA
authors.lastname: Kesel'man
authors.forename: V M
authors.initials: VM
authors.lastname: Gorodetskiĭ
authors.forename: D V
authors.initials: DV
authors.lastname: Kharazishvili
authors.forename: M Zh
authors.initials: MZh
authors.lastname: Aleksanian
authors.forename: T N
authors.initials: TN
authors.lastname: Moiseeva
authors.forename: E G
authors.initials: EG
authors.lastname: Gemdzhian
authors.forename: I A
authors.initials: IA
authors.lastname: Vorob'ev
mesh_terms: D018806:APACHE; D000328:Adult; D000402:Airway Obstruction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal; D008223:Lymphoma / Q000150:complications* / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014139:Tracheostomy